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Abstract
Background: Aedes aegypti (Linnaeus, 1762) and Aedes albopictus (Skuse, 1894) are the main vectors of dengue
(DENV) and chikungunya (CHIKV) viruses worldwide. As there is still no vaccine or specific treatment for DENV and
CHIKV, vector control remains the cornerstone of prevention and outbreak control. Unfortunately, vector control
programs are facing operational challenges with mosquitoes becoming resistant to commonly used insecticides in
several areas through the world. Throughout Central Africa no recent data are available susceptible/resistant status
of either vector species since the introduction/arrival of Ae. albopictus in this area. We therefore studied the level of
resistance of these two major vectors to insecticides commonly used in Africa for mosquito control.
Results: Aedes aegypti and Ae. albopictus were sampled in six urban localities of Cameroon (Garoua, Bertoua,
Yaoundé, Bafia, Buea) and Gabon (Libreville). Larval bioassays, carried out to determine the lethal concentrations
(LC50 and LC95) and resistance ratios (RR50 and RR95) suggested that both vector species were susceptible to Bti
(Bacillus thuringiensis var israeliensis) and temephos. Bioassays were also performed on adults using WHO diagnostic
test kits to assess phenotypic resistance to deltamethrin, DDT, fenitrothion and propoxur. These experiments
showed that one population of Ae. aegypti (Libreville) and two populations of Ae. albopictus (Buea and Yaoundé)
were resistant to DDT (mortality 36% to 71%). Resistance to deltamethrin was also suspected in Ae. albopictus from
Yaoundé (83% mortality). All other field mosquito populations were susceptible to deltamethrin, DDT, fenitrothion
and propoxur. No increase in the knockdown times (Kdt50 and Kdt95) was noted in the Yaoundé resistant
population compared to other Ae. albopictus populations, suggesting the possible involvement of metabolic
resistance to deltamethrin and DDT.
Conclusion: In view of the recent increase in dengue and chikungunya outbreaks in Central Africa, these unique
comparative data on the insecticide susceptibility of Ae. aegypti and Ae. albopictus could help public health services
to design more effective vector control measures.
Background
Dengue virus (DENV, Flaviviridae, Flavivirus) and chi-
kungunya virus (CHIKV, Togaviridae, Alphavirus)a r e
mosquito-borne viruses of medical concern in most tro-
pical regions. With about 50-100 million reported cases
annually, including 500 000 severe cases of dengue hae-
morrhagic fever (DHF) or dengue shock syndrome (DSS),
DENV is the most prevalent mosquito-borne human
virus worldwide [1]. In West and Central Africa, where
DENV epidemics remained limited until 5 years ago, the
number of outbreaks or case reports has increased signif-
icantly in several areas, including Cameroon in 2006
[2,3], Gabon in 2007 [4], and West African countries
such as Mali in 2008, and Cape Verde and Senegal in
2009 [5]. Similarly, CHIKV, which previously caused only
sporadic outbreaks in sub-Saharan Africa [6], has
recently emerged in several urban epidemic foci in
Central Africa [4].
Aedes aegypti (Linnaeus, 1762) and Aedes albopictus
(Skuse, 1894) are the main epidemic vectors of DENV and
CHIKV worldwide [2,7]. Both species occur in sub-
Saharan Africa: Ae. aegypti is native to Africa and Ae.
albopictus has recently invaded several Central African
countries [8]. Recent observations in Cameroon [9] and
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environments.
As there is still no vaccine or specific treatment for
DENV or CHIKV, vector control remains the corner-
stone of prevention and outbreak control. Conventional
control strategies rely on the reduction of larval sources
by eradicating water-holding containers that serve as lar-
val habitats, and by using larvicides (e.g. temephos and
Bacillus thuringiensis var israeliensis [Bti]) in natural
and/or domestic breeding sites [11]. Space spraying
(using pyrethroids or organophosphates) is generally
used when larval source reduction fails to reduce the
density of adult mosquitoes, and also during outbreak
situations [12]. Unfortunately, many vector control pro-
grams are threatened by the development of insecticide
resistance in Ae. aegypti and Ae. albopictus [13-16].
Resistance to multiple insecticides (e.g. pyrethroids and
organophosphates) has been reported in Ae. aegypti in
South-East Asia [17,18], South America and the Carib-
bean [19-21]. There have been fewer reports of insecti-
cide resistance in Ae. albopictus [15,22], although a
significant decrease in susceptibility to permethrin,
malathion and temephos has been observed in Thailand
[14]. In West and Central Africa, most available data on
pesticide resistance concern Ae. aegypti but date back
more than 30-40 years [23], while virtually no such data
are available for Ae. albopictus, owing to its recent
introduction in Africa. In order to implement effective
and sustainable arbovirus vector control measures, there
is an urgent need to determine the susceptibility of the
two major vectors of DENV and CHIK to insecticides
commonly used for mosquito control. We therefore
examined the distribution and insecticide susceptibility
of both larval and adult Ae. aegypti and Ae. albopictus
populations in sentinel sites from Central Africa
(Cameroon and Gabon) using WHOPES-approved pro-
cedures [24,25].
Materials and methods
Mosquito sampling
Aedes aegypti and Ae. albopictus mosquitoes were sampled
as larvae or pupae in six urban localities (Figure 1): Garoua
(09°16’N; 13°25’E), Bertoua (04°33’N; 13°46’E), Yaoundé
(03°54’N;12°29’E), Bafia (04°44’N; 11°11’E) and Buea (04°
09’N; 09°13’E°) in Cameroon in April 2007, and Libreville,
Gabon (00°23’N; 09°27’E) in June 2007. An additional Ae.
aegypti population (Bénoué) was sampled in the Bénoué
National Park (08°15’N; 13°49’E). The latter population,
which is sylvan and thus considered as naïve to pesticide,
was used as a susceptible reference strain. Immature stages
(field generation, F0) were collected from water in domes-
tic (e.g. jars, tanks), peri-domestic (e.g. tires) and natural
environments (e.g. tree holes). For each sampling site, lar-
vae or pupae from 2-6 larval breeding places were
collected, stored in plastic boxes and transferred to insec-
taries for rearing to the adult stage. Once identified as Ae.
aegypti or Ae. albopictus, mosquitoes of the same species
and from the same locality were pooled to prevent
inbreeding. Mosquitoes were reared to generation F1 for
larval and adult bioassays. Mosquito populations were
maintained at insectaries conditions (27°C +/- 2°C; relative
humidity 80% +/-10%) and females were fed on rabbits to
complete their gonotrophic cycle.
Larval bioassay
The susceptibility of larvae to temephos (organopho-
sphate, Sigma Aldrich-Pestanal, Seelze, Germany) and
Bti (VectoBac, Bayer CropScience, Monheim, Germany)
was assessed using standard WHO bioassays [24]. Stock
solutions and serial dilutions were prepared in 95%
ethanol (temephos) or mineral water (Bti)a n dw e r e
stored at +4°C. Each bioassay used 25 late-third or
early-fourth instars in plastic cups with 99 ml of mineral
water and 1 ml insecticide solution at the required con-
centration. We used 5 concentrations in the range of
activity of each insecticide and 50 to 100 larvae per con-
centration (with two to four replicates, depending on
t h es a m p l ea n dt h en u m b e ro fl a r v a ea v a i l a b l e ) .E a c h
bioassay included a control group which received 1 mL
of ethanol (for temephos) or 1 mL of mineral water (for
Bti) only. Tests were run at 27°C ± 2°C, and mortality
was assessed after 24 h of insecticide exposure. For each
mosquito strain, one replicate corresponded to a single
rearing batch.
Adult bioassay
The procedure used for adult bioassays followed the stan-
dard WHO protocol [25]. Papers were impregnated using
acetone solutions of insecticide and silicone oil as the
carrier at the “Laboratoire de Lutte contre les Insectes
Nuisibles” (LIN), Montpellier, France (WHO Collaborating
Centre) using diagnostic concentrations defined for Aedes
laboratory strain (Bora) susceptible reference strain [17].
Four technical-grade compounds representing the 4 major
classes of insecticide (carbamate, organochlorine, pyre-
throid and organophosphate) were used as follows: 0.3%
propoxur (Bayer CropScience, Monheim, Germany), 4%
DDT (Hindustan Insecticides Limited, New Delhi, India),
0.06% deltamethrin (Agrevo Environmental Health,
Berkhamsted UK) and 0.5% fenitrothion (SUPELCO, Belle-
fonte, USA). Two to four batches of 25 non-blood-fed
females (2-4 days of age) were introduced into exposure
tubes containing impregnated filter papers for 60 minutes.
The number of knocked-down (Kd) mosquitoes was
recorded every 5 minutes. The mosquitoes were then
transferred to a recovery tube containing 10% glucose solu-
t i o na n dm a i n t a i n e da t2 7 ° C±2 ° Cw i t h8 0 %±1 0 %r e l a t i v e
humidity. Mortality was recorded 24 hours post-exposure.
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control.
Data analysis
Larval and adult mortality rates were corrected using
Abbott’s formula (Abbott 1925) in case of control
mortality >5% but less than 20%. Data from larval bioas-
says were analyzed with Win DL 2.0 software [26], which
uses the iterative method of maximum likelihood to fit a
linear regression between the log of the insecticide con-
centration and the probit of mortality. Goodness-of-fit
was estimated with the Pearson c
2 test. Win DL 2.0
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Figure 1 Aedes aegypti and Ae. albopictus sampling sites in Cameroon and Gabon.
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estimates of lethal concentrations (LC50 and LC95)w i t h
their 95% confidence intervals (CI). Resistance ratios
(RR50 and RR95) of each population compared to the
Bénoué strain of Ae. aegypti (used as reference) were cal-
culated as follows: RR50 =L C 50 assay/LC50 reference;
RR95 =L C 95 assay/LC95 reference. A mosquito popula-
tion was considered susceptible when RR50 was less than
2, potentially resistant when RR50 was between 2 and 5,
and resistant when RR50 was over 5. For adult bioassays,
resistant/susceptible status was defined according to
WHO criteria [27]. Mosquitoes were considered suscep-
tible if the mortality rates were greater than 97% and
resistant if mortality rates were less than 80%. Mortality
rates between 80-97% suggested possible resistance.
For deltamethrin and DDT, the knockdown times
(KdT50 and KdT95) and their 95% confidence intervals
were estimated with Win DL 2.0 software.
Results
Larval bioassay
Larval bioassays using Bti showed that LC50 and LC95 for
Ae. albopictus ranged from 0.18 mg/l for the Bénoué strain
(susceptible reference strain) to 0.69 mg/L for the
Yaoundé and Buea populations. Against Ae. aegypti, Bti
acted in a similar range of concentrations, with LC50 and
LC95 ranging from 0.18 mg/L for Garoua to 0.91 mg/L for
B a f i a( T a b l e1 ) .R R 50 ranged from 1.00 (Garoua) to 1.50
(Bertoua) and RR95 from 1.13 (Libreville) to 2.84 (Bafia).
These values and their 95%CIs indicated that all Ae.
aeggyti and Ae. albopictus populations were similarly sus-
ceptible to Bti.
Against Ae. aegypti, bioassays showed that temephos
LC50 values ranged from 0.004 mg/L (Garoua) to 0.009
mg/l (Bertoua) and the LC95 from 0.006 mg/L (Garoua) to
0.026 mg/L (Bertoua) (Table 2). RR50 ranged from 0.75
(Garoua) to 1.75 (Bertoua) and RR95 from 0.66 (Garoua)
to 2.68 (Bertoua). These findings suggested that all the
mosquito samples tested were susceptible to temephos.
Concerning the Bertoua sample, although the RR95 value
was over 2 indicating a suspected resistance, the IC values
did not confirm this trend. LC50 values for Ae. albopictus
ranged from 0.005 (Bertoua) to 0.008 mg/L (Libreville)
and LC95 values from 0.008 (Yaoundé) to 0.017 mg/L
(Libreville). RR50 ranged from 0.92 (Bertoua) to 1.43 mg/L
(Libreville) and RR95 from 0.82 (Yaoundé) to 1.75 mg/L
(Libreville), indicating susceptibility of all the mosquito
populations to temephos.
Adult bioassay
After 24 h post-exposure, one population of Ae. aegypti
(Libreville) and two populations of Ae. albopictus (Buea
and Yaoundé) were resistant to DDT (mortality 36% to
71%). DDT mortality rates suggested probable resistance
in the Garoua Ae. aegypti population (97%) and the
Bertoua Ae. albopictus population (80%). Probable resis-
tance to deltamethrin was also detected in the Yaoundé
Ae. albopictus population (80%). All Ae. aegypti except
Yaoundé, and all Ae. albopictus populations were sus-
ceptible to deltamethrin, propoxur and fenitrothion
(99-100%) (Table 3).
The estimated knockdown times (KdT) for Ae. aegypti
mosquitoes exposed to deltamethrin indicated that the
KdT50 and KdT95 values of the field populations were
similar (overlapping 95%CIs) to those of the reference
strain (Table 4). KdT50 values recorded in Yaoundé and
Buea Ae. albopictus strains were higher than for the
reference strain. Despite the ICs calculated for these two
strains did not overlapped with the IC of the reference,
t h ei n c r e a s ei nK d Ts e e m e dn os i g n i f i c a n t( P>o r=
0.05). The DDT KdT50 for all Ae. albopictus samples
and the KdT95 for Ae. albopictus Bertoua were signifi-
cantly higher than the corresponding values for all Ae.
aegypti samples. These differences in KdT between Ae.
aegypti and Ae. albopictus may be physiological and/or
species-dependent.
Discussion
All Ae. aegypti and Ae. albopictus samples collected in
Cameroon and Libreville (Gabon) were susceptible to
Bti and temephos. Resistance to Bti has been described
in Culex pipiens in the USA [28] and suspected in
Aedes rusticus in France [29], but no resistance to this
pesticide has been reported to date in Ae. aegypti or Ae.
albopictus worldwide. Temephos is the most widely
used larvicide for dengue vector control. Resistance to
this organophosphate has been recorded in Ae. aegypti
in Asia [30-34] and South America [35-37], and in Ae.
albopictus in Malaysia [38] and Thailand [14]. Mouchet
et al. [23] observed full susceptibility of Ae. aegypti lar-
vae to temephos in Cameroon and Gabon (Libreville
and Yaoundé) during the 1970s. Up to now, larvicides
targeting these two species have rarely been used in
African countries, thus explaining the persistent suscept-
ibility to temephos and Bti in this part of the world.
WHO bioassays carried out on adult mosquitoes
showed DDT resistance in one Ae. aegypti population
from Gabon (Libreville) and two Ae. albopictus popula-
tions from Cameroun (Buea and Yaoundé). In addition,
DDT resistance was suspected in the Ae. albopictus sam-
ple from Bertoua. DDT resistance has been widely found
in Ae. aegypti worldwide, including in Cameroon [23].
Kdr mutation of the voltage-gated sodium channel has
been found to confer resistance to DDT in Ae. aegypti
[39] but detoxifying enzymes such as glutathione S-trans-
ferases (GSTs) can also play a key role in DDT metabo-
lism and resistance [40]. Although DDT resistance has
also been recorded in Ae. albopictus in Thailand and
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Page 4 of 8Table 1 Susceptibility of Ae. aegypti and Ae. albopictus larvae to Bti
Sample N Regression line Pearson c
2 goodness of fit LC50
(95% CI)
LC95
(95% CI)
RR50 RR95
Ae. aegypti
Garoua 493 Y = 5.67X + 4.15 0.69 0.18
(0.03-0.45)
0.36
(0.30-0.45)
1.00 1.13
Bertoua 498 Y = 3.84X + 2.13 0.62 0.27
(0.19-0.39)
0.75
(0.20-2.77)
1.50 2.34
Yaoundé 252 Y = 8.77X + 5.76 0.27 0.22
(0.20-0.44)
0.34
(0.26-0.44)
1.22 1.06
Bafia 500 Y = 2.99X + 1.75 0.54 0.25
(0.21-0.31)
0.91
(0.17-4.89)
1.39 2.84
Libreville 500 Y = 6.06X + 4.28 0.21 0.19
(0.09-0.24)
0.36
(0.32-0.46)
1.06 1.13
Ae. albopictus
Yaoundé 500 Y = 1.91X - 0.04 0.64 0.19
(0.17-0.21)
0.69
(0.26-1.85)
1.05 1.06
Bertoua 477 Y = 16.31X + 9.32 0.94 0.27
(0.25-0.28)
0.34
(0.32-0.40)
1.50 1.13
Buea 375 Y = 3.08X + 2.13 0.51 0.20
(0.10-0.39)
0.69
(0.26-1.85)
1.11 1.06
Reference strain 496 Y = 7.04X + 5.11 0.40 0.18
(0.11-0.22)
0.32
(0.29-0.36)
N: Total number of mosquitoes assayed; 50% and 95% lethal concentrations, LC50 and LC95, are expressed in mg/liter; 95%CI: 95% confidence interval; p > 0.05
suggests a well-fitting model, P < 0.05 suggests an invalid model population.
Table 2 Susceptibility of Ae. aegypti and Ae. albopictus larvae to Temephos
Sample N Regression line Pearson c
2 goodness of fit LC50
(95%CI)
LC95
(95%CI)
RR50 RR95
Ae. aegypti
Garoua 500 Y = 10.68X + 25.82 0.36 0.0040
(0.0037-0.0042)
0.0064
(0.0060-0.0070)
0.75 0.66
Bertoua 500 Y = 3.57X + 7.28 0.48 0.0090
(0.0048-0.0170)
0.0260
(0.0022-0.3100)
1.75 2.68
Yaoundé 253 Y = 11.36X + 25.68 0.30 0.0055
(0.0052-0.006)
0.0076
(0.0067-0.0100)
1.04 0.78
Bafia 500 Y = 7.07X + 16.04 0.006 0.0053
(0.0047-0.0084)
0.0092
(0.0068-0.0410)
1.02 0.95
Libreville 500 Y = 8.17X + 19.56 0.061 0.0043
(0.0020-0.0081)
0.0068
(0.0051-0.0080)
0.81 0.70
Ae. albopictus
Bertoua 493 Y = 6.75X + 15.58 0.14 0.0049
(0.0013-0.0180)
0.0086
(0.0061-0.0120)
0.92 0.89
Yaoundé 497 Y = 8.00X + 18.38 0.30 0.0050
(0.0021-0.0110)
0.0080
(0.0064-0.0100)
0.94 0.82
Buea 375 Y = 9.57X + 20.55 0.27 0.0071
(0.0065-0.0200)
0.012
(0.0087-0.0500)
1.34 1.03
Libreville 275 Y = 4.56X + 25.68 0.11 0.0076
(0.0023-0.0240)
0.017
(0.0017-0.1700)
1.43 1.75
Reference strain 500 Y = 6.22X + 14.17 0.57 0.0053
(0.0035-0.0079)
0.0097
(0.0073-0.012)
N: Total number of mosquitoes assayed; 50% and 95% lethal concentrations, LC50 and LC95, are expressed in mg/liter; 95%CI: 95% confidence interval; p > 0.05
suggests a well-fitting model, P < 0.05 suggests an invalid model population.
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unclear.
This study also showed full susceptibility of Ae.
aegypti and Ae. albopictus to deltamethrin, except in
Yaoundé where the Ae. albopictus population showed
mortality rates of around 80%, strongly suggesting resis-
tance. Pyrethroid resistance in Ae. aegypti is widespread
[43,15] and is usually associated with an altered amino
acid sequence of the target protein, the sodium channel
that confers knockdown resistance when altered (the so-
Table 3 Aedes aegypti and Ae. albopictus mortality rates 24 h after exposure to insecticides at diagnostic doses
Mortality rate (%)
0.06% Deltamethrin 4% DDT 0.3% Propoxur 0.5% Fenitrothion
Assay Control Assay Control Assay Control Assay Control
Ae. aegypti
Garoua 100 (89) 2 (50) 96.8 (95) 8 (50) 100 (100) 8 (50) 100 (99) 2 (50)
Bertoua 100 (100) 2 (50) - - 100 (98) 2 (50)
Yaoundé 100 (95) 4 (50) - - 100 (96) 4 (50)
Bafia 100 (97) 4 (50) - - 100 (97) 4 (50)
Libreville 100 (97) 0 (50) 70.7 (99) 0 (50) 99 (100) 0 (50) 100 (99) 0 (50)
Ae. albopictus
Bertoua 100 (80) 0 (50) 80.5 (87) 8 (50) 100 (94) 8 (50) 100 (61) 0 (50)
Yaoundé 83.3 (96) 2 (50) 36.3 (91) 12 (50) 100 (96) 12 (50) 100 (98) 2 (50)
Buea 100 (50) 4 (50) 47.0 (85) 2 (50) 100 (92) 2 (50) 100 (50) 4 (50)
Reference strain 100 (96) 2 (50) - - 100 (100) 2 (50)
Numbers in brackets indicate the number of mosquitoes assayed; -: sample not assayed.
Table 4 Knockdown times of Ae. aegypti and Ae. albopictus exposed to 0.06% deltamethrin and 4% DDT
Locality Ae. aegypti Ae. albopictus
KdT50
(95%CI); P*
KdT95
(95%CI); P*
KdT50
(95%CI); P*
KdT95
(95%CI); P*
Deltamethrin Deltamethrin
Garoua 5.3
(4.7-5.9); P = 0.47
11.4
(9.7-14.2); P = 0.24
--
Bertoua 5.8
(3.3-8.2); P = 0.46
24.6
(16.6-51.4); P = 0.025
7.8
(7.3-8.3); P = 0.25
15.9
(14.4-18.0); P = 0.38
Yaoundé 6.7
(3.7-9.7); P = 0.35
22.8
(15.0-58.4); P = 0.05
11.2
(10.6-11.8); P = 0.06
17.3
(16.3-19.0); P = 0.28
Bafia 5.4
(3.3-7.4), P = 0.48
14.6
(10.1-36.9); P = 0.49
--
Buea - - 11.7
(10.2-13.3); P = 0.06
21.2
(18.1-27.4); P = 0.09
Libreville 5.9
(5.1-6.8); P = 0.45
13.4
(11.2-17.9); P = 0.40
--
Reference strain 5.5
(4.6-6.3)
14.5
(11.9-19.4)
--
DDT DDT
Garoua 53.6
(49.9-59.2)
101.9
(84.0-146.0)
--
Bertoua - - 84.8
(72.8-106.9)
290.8
(200.7-523.0)
Yaoundé - - 77.4
(68.5-113.2)
109.2
(86.1-235.3)
Buea - - 68.0
(63.6-78.2)
93.9
(80.7-131.9)
Libreville 58.7
(55.8-62.7)
107.7
(94.6-129.2)
--
KdT: Knockdown times expressed in minutes; 95%CI: 95% confidence interval. *: P is the probability of homogeneity between the sample and the reference
(Mantel-Haenszel chi square).
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also been linked to an increase in metabolic process
through over-transcription of detoxification genes [21].
Although the number of studies reporting insecticide
resistance in Ae. albopictus has increased this decade
[17,41,42,45,46], few have shown evidence of pyrethroid
resistance [14]. The Kdr mutation has been found in Ae.
aegypti [39,16] but has never been reported in Ae. albo-
pictus. Further molecular and biochemical studies are
needed to identify the genetic basis of pyrethroid resis-
tance in Ae. albopictus in Yaoundé. The absence of
cross-resistance between DDT and deltamethrin in all
mosquito populations (except Ae. albopictus collected
in Yaoundé) suggests the involvement of metabolic
resistance rather than a target site modification (Kdr
mutation) in the sodium channel. It is unclear whether
cross-resistance to deltamethrin and DDT in the Ae.
albopictus population in Yaoundé is due to common or
different resistance mechanisms.
The source of DDT and deltamethrin resistance
observed here in DENV and CHIKV vectors is unclear.
Indeed, in Central Africa, insecticide treatment specifi-
cally targeting Ae. aegypti or Ae. albopictus is extremely
limited. It is possible that insecticides used to control
other insects of medical or agricultural interest exert
indirect selection pressure on these two mosquito spe-
cies. For example, indoor residual spraying of DDT for
malaria control [47] was suspected of favouring the
selection of DDT resistance in Anopheles [48] as well as
in Aedes [42,45]. Contamination of larval breeding
places by insecticides used in agriculture (cotton, vegeta-
bles) has also been shown to select for DDT and pyre-
throid resistance in malaria vectors [48-52]. Concerning
Ae. albopictus, which recently spread to Cameroon [8],
one cannot exclude the possibility that the invading
population possessed a resistance background.
Conclusion
This is the first study of the susceptibility status of Ae.
aegypti and Ae. albopictus to various insecticides in Cen-
tral Africa. The increase in dengue and chikungunya out-
breaks in this region calls for more robust surveillance and
vector control. Our observations could help to guide
insecticide-based strategies, although broader monitoring
of insecticide resistance in Aedes mosquitoes is needed.
Further molecular and biochemical studies are also needed
to determine the mechanisms involved in insecticide resis-
tance among arboviruses vectors in Central Africa.
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